HMPL-306

Near Add Your Location

Accepting patients

HMPL-306

A Phase 1, Open-Label, Multicenter Study of HMPL-306 in Advanced Hematological Malignancies With Isocitrate Dehydrogenase (IDH) Mutations
Learn more
  • IDH1 Inhibitor
  • MIDH2 Inhibitor
  • Phase 1